Literature DB >> 6103125

Captopril: reversible renal failure with severe hyperkalaemia.

A Grossman, D Eckland, P Price, C R Edwards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103125

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Inhibitors of angiotensin I converting enzyme for treating hypertension.

Authors: 
Journal:  Br Med J       Date:  1980-09-06

Review 2.  Angiotensin converting enzyme inhibitors and moderate hypertension.

Authors:  D McAreavey; J I Robertson
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

3.  Captopril in various forms of severe therapy-resistant hypertension.

Authors:  A Studer; T Lüscher; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-01-15

4.  Repeated renal failure with use of captopril in a cystinotic renal allograft recipient.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

5.  Long-term effect of captopril on kidney function in various forms of hypertension.

Authors:  W Vetter; M Wehling; E C Foerster; U Kuhlmann; H J Boerlin; P Greminger; H Vetter
Journal:  Klin Wochenschr       Date:  1984-08-01

Review 6.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 7.  An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.

Authors:  H S Buttar
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

8.  [Reproducibility of acute captopril-induced renal insufficiency with enalapril].

Authors:  W Cremer
Journal:  Klin Wochenschr       Date:  1984-01-02

Review 9.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 10.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.